Introduction. Ziprasidone in Schizophrenia: From Acute Treatment to Long-Term Management

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Schizophrenia is a highly complex, chronic, often lifelong, mental illness that severely compromises social, intellectual, and occupational functioning. About 1% of the population will develop schizophrenia, and annually more than 2 million Americans suffer from the disorder.1 People with schizophrenia on average live 15 fewer years than individuals in the general population, dying prematurely of natural (e.g., cardiovascular and respiratory diseases) as well as unnatural causes (primarily suicide).2

J Clin Psychiatry 2003;64(suppl 19):3-5